While the mechanism of action was not studied in T-cell lymphoma [62], NFE2L3s protective role in breast cancer was due to its inhibition of cell growth and metastasis by suppression of AKT signaling, MMP expression and epithelial–mesenchymal transition (EMT) [18]. Here, AKT1 is linked to breast carcinoma.